We are analyzing https://link.springer.com/article/10.1186/s13231-016-0023-0.

Title:
Hypoxia after stroke: a review of experimental and clinical evidence | Experimental & Translational Stroke Medicine
Description:
Background Hypoxia is a common occurrence following stroke and associated with poor clinical and functional outcomes. Normal oxygen physiology is a finely controlled mechanism from the oxygenation of haemoglobin in the pulmonary capillaries to its dissociation and delivery in the tissues. In no organ is this process more important than the brain, which has a number of vascular adaptions to be able to cope with a certain threshold of hypoxia, beyond which further disruption of oxygen delivery potentially leads to devastating consequences. Hypoxia following stroke is common and is often attributed to pneumonia, aspiration and respiratory muscle dysfunction, with sleep apnoea syndromes, pulmonary embolism and cardiac failure being less common but important treatable causes. As well as treating the underlying cause, oxygen therapy is a vital element to correcting hypoxia, but excessive use can itself cause molecular and clinical harm. As cerebral vascular occlusion completely obliterates oxygen delivery to its target tissue, the use of supplemental oxygen, even when not hypoxic, would seem a reasonable solution to try and correct this deficit, but to date randomised clinical trials have not shown benefit. Conclusion Whilst evidence for the use of supplemental oxygen therapy is currently lacking, it is vital to rapidly identify and treat all causes of hypoxia in the acute stroke patient, as a failure to will lead to poorer clinical outcomes. The full results of a large randomised trial looking at the use of supplemental oxygen therapy are currently pending.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Graphic Design
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

stroke, oxygen, article, google, scholar, pubmed, patients, hypoxia, acute, study, clinical, cerebral, blood, treatment, cas, flow, pneumonia, saturation, respiratory, sleep, risk, review, pulmonary, brain, supplemental, saturations, hypoxic, sao, atp, group, central, found, therapy, nocturnal, care, roffe, controlled, effects, ischemic, significant, med, function, delivery, shown, state, neurological, dysphagia, controls, normal, tissue,

Topics {✒️}

na+/ca2+ atp driven pump article download pdf gov/ct2/show/nct00414726 active energy-driven process phillip ferdinand hypoxia-tolerant animal models oxygen free-radical species cerebral hypoxic ischaemia delayed post-hypoxic leukoencephalopathy long-term clinical benefit quasi-randomized controlled trial article ferdinand hypoxic-ischaemic brain injury open-label hypoxic-ischemic brain injury cerebral vascular response privacy choices/manage cookies term=singhal&rank=1 clinical stroke research cerebral blood flow arterial oxygen pressure european economic area white matter hyperintensities creative commons license smith cj controlled clinical trial randomised clinical trials alter surfactant properties masked endpoint neurogenic pulmonary edema permanent cerebral injury patient related difficulties case controlled trial paediatr respir rev randomised controlled trials cerebral blood volume supplemental oxygen therapy continuous supplemental oxygen normobaric oxygen therapy randomized controlled trial cerebral ischemic preconditioning quasi-randomised study affect functional outcome large randomised trial free radicals facilitated magnetic resonance imaging neutralise free radicals barthel index scores dwi lesion volumes update anaesth

Questions {❓}

Can a novel clinical risk score improve pneumonia prediction in acute stroke care?
Does feeding alter arterial oxygen saturation in patients with acute stroke?
How is pneumonia diagnosed in clinical stroke research?
Is overnight tube feeding associated with hypoxia in stroke?
Is tube feeding associated with altered arterial oxygen saturation in stroke patients?
Should stroke victims routinely receive supplemental oxygen?
Gov/ct2/show/NCT00414726?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Hypoxia after stroke: a review of experimental and clinical evidence
         description:Hypoxia is a common occurrence following stroke and associated with poor clinical and functional outcomes. Normal oxygen physiology is a finely controlled mechanism from the oxygenation of haemoglobin in the pulmonary capillaries to its dissociation and delivery in the tissues. In no organ is this process more important than the brain, which has a number of vascular adaptions to be able to cope with a certain threshold of hypoxia, beyond which further disruption of oxygen delivery potentially leads to devastating consequences. Hypoxia following stroke is common and is often attributed to pneumonia, aspiration and respiratory muscle dysfunction, with sleep apnoea syndromes, pulmonary embolism and cardiac failure being less common but important treatable causes. As well as treating the underlying cause, oxygen therapy is a vital element to correcting hypoxia, but excessive use can itself cause molecular and clinical harm. As cerebral vascular occlusion completely obliterates oxygen delivery to its target tissue, the use of supplemental oxygen, even when not hypoxic, would seem a reasonable solution to try and correct this deficit, but to date randomised clinical trials have not shown benefit. Whilst evidence for the use of supplemental oxygen therapy is currently lacking, it is vital to rapidly identify and treat all causes of hypoxia in the acute stroke patient, as a failure to will lead to poorer clinical outcomes. The full results of a large randomised trial looking at the use of supplemental oxygen therapy are currently pending.
         datePublished:2016-12-07T00:00:00Z
         dateModified:2016-12-07T00:00:00Z
         pageStart:1
         pageEnd:8
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13231-016-0023-0
         keywords:
            Cerebral hypoxia
            Acute stroke
            Oxygen therapy
            Oxygen physiology
            Cerebral blood flow
            Neurosciences
            Neurology
            Cardiology
            Intensive / Critical Care Medicine
         image:
         isPartOf:
            name:Experimental & Translational Stroke Medicine
            issn:
               2040-7378
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Phillip Ferdinand
               affiliation:
                     name:The Royal Wolverhampton NHS Trust
                     address:
                        name:The Royal Wolverhampton NHS Trust, Wolverhampton, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Christine Roffe
               affiliation:
                     name:Keele University
                     address:
                        name:Stroke Research in Stoke, Institute for Applied Clinical Studies, Keele University, Keele, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Hypoxia after stroke: a review of experimental and clinical evidence
      description:Hypoxia is a common occurrence following stroke and associated with poor clinical and functional outcomes. Normal oxygen physiology is a finely controlled mechanism from the oxygenation of haemoglobin in the pulmonary capillaries to its dissociation and delivery in the tissues. In no organ is this process more important than the brain, which has a number of vascular adaptions to be able to cope with a certain threshold of hypoxia, beyond which further disruption of oxygen delivery potentially leads to devastating consequences. Hypoxia following stroke is common and is often attributed to pneumonia, aspiration and respiratory muscle dysfunction, with sleep apnoea syndromes, pulmonary embolism and cardiac failure being less common but important treatable causes. As well as treating the underlying cause, oxygen therapy is a vital element to correcting hypoxia, but excessive use can itself cause molecular and clinical harm. As cerebral vascular occlusion completely obliterates oxygen delivery to its target tissue, the use of supplemental oxygen, even when not hypoxic, would seem a reasonable solution to try and correct this deficit, but to date randomised clinical trials have not shown benefit. Whilst evidence for the use of supplemental oxygen therapy is currently lacking, it is vital to rapidly identify and treat all causes of hypoxia in the acute stroke patient, as a failure to will lead to poorer clinical outcomes. The full results of a large randomised trial looking at the use of supplemental oxygen therapy are currently pending.
      datePublished:2016-12-07T00:00:00Z
      dateModified:2016-12-07T00:00:00Z
      pageStart:1
      pageEnd:8
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13231-016-0023-0
      keywords:
         Cerebral hypoxia
         Acute stroke
         Oxygen therapy
         Oxygen physiology
         Cerebral blood flow
         Neurosciences
         Neurology
         Cardiology
         Intensive / Critical Care Medicine
      image:
      isPartOf:
         name:Experimental & Translational Stroke Medicine
         issn:
            2040-7378
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Phillip Ferdinand
            affiliation:
                  name:The Royal Wolverhampton NHS Trust
                  address:
                     name:The Royal Wolverhampton NHS Trust, Wolverhampton, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Christine Roffe
            affiliation:
                  name:Keele University
                  address:
                     name:Stroke Research in Stoke, Institute for Applied Clinical Studies, Keele University, Keele, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Experimental & Translational Stroke Medicine
      issn:
         2040-7378
      volumeNumber:8
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Royal Wolverhampton NHS Trust
      address:
         name:The Royal Wolverhampton NHS Trust, Wolverhampton, UK
         type:PostalAddress
      name:Keele University
      address:
         name:Stroke Research in Stoke, Institute for Applied Clinical Studies, Keele University, Keele, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Phillip Ferdinand
      affiliation:
            name:The Royal Wolverhampton NHS Trust
            address:
               name:The Royal Wolverhampton NHS Trust, Wolverhampton, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Christine Roffe
      affiliation:
            name:Keele University
            address:
               name:Stroke Research in Stoke, Institute for Applied Clinical Studies, Keele University, Keele, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:The Royal Wolverhampton NHS Trust, Wolverhampton, UK
      name:Stroke Research in Stoke, Institute for Applied Clinical Studies, Keele University, Keele, UK

External Links {🔗}(268)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.23s.

LINK . SPRINGER . COM {}